These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 11935266)

  • 21. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies.
    Duda JE; Giasson BI; Chen Q; Gur TL; Hurtig HI; Stern MB; Gollomp SM; Ischiropoulos H; Lee VM; Trojanowski JQ
    Am J Pathol; 2000 Nov; 157(5):1439-45. PubMed ID: 11073803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders.
    Tanji K; Mori F; Kakita A; Zhang H; Kito K; Kamitani T; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2007 Oct; 114(4):365-71. PubMed ID: 17549501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining.
    Gómez-Tortosa E; Newell K; Irizarry MC; Sanders JL; Hyman BT
    Acta Neuropathol; 2000 Apr; 99(4):352-7. PubMed ID: 10787032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Alpha-synucleinopathies].
    Ferrer I
    Neurologia; 2001 Apr; 16(4):163-70. PubMed ID: 11412709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.
    Rockenstein E; Mallory M; Hashimoto M; Song D; Shults CW; Lang I; Masliah E
    J Neurosci Res; 2002 Jun; 68(5):568-78. PubMed ID: 12111846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.
    Suzuki K; Iseki E; Togo T; Yamaguchi A; Katsuse O; Katsuyama K; Kanzaki S; Shiozaki K; Kawanishi C; Yamashita S; Tanaka Y; Yamanaka S; Hirayasu Y
    Acta Neuropathol; 2007 Nov; 114(5):481-9. PubMed ID: 17653558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of alpha-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex.
    Sebeo J; Hof PR; Perl DP
    Acta Neuropathol; 2004 Jun; 107(6):497-503. PubMed ID: 15024581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease.
    Hishikawa N; Hashizume Y; Yoshida M; Sobue G
    Neuropathol Appl Neurobiol; 2001 Oct; 27(5):362-72. PubMed ID: 11679088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuft-shaped astrocytes in Lewy body disease.
    Hishikawa N; Hashizume Y; Yoshida M; Niwa J; Tanaka F; Sobue G
    Acta Neuropathol; 2005 Apr; 109(4):373-80. PubMed ID: 15668789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-synuclein immunoreactivity and ultrastructural study of glial cytoplasmic inclusions in multiple system atrophy.
    Wang Y; Lü C; Ye Z
    Chin Med J (Engl); 2002 Oct; 115(10):1491-5. PubMed ID: 12490094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation of Hsc70 and Hsp70 in glial cytoplasmic inclusions in patients with multiple system atrophy.
    Kawamoto Y; Akiguchi I; Shirakashi Y; Honjo Y; Tomimoto H; Takahashi R; Budka H
    Brain Res; 2007 Mar; 1136(1):219-27. PubMed ID: 17240362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
    Popescu A; Lippa CF; Lee VM; Trojanowski JQ
    Arch Neurol; 2004 Dec; 61(12):1915-9. PubMed ID: 15596612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
    Schell H; Hasegawa T; Neumann M; Kahle PJ
    Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.
    Parkkinen L; Kauppinen T; Pirttilä T; Autere JM; Alafuzoff I
    Ann Neurol; 2005 Jan; 57(1):82-91. PubMed ID: 15562510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of medullary regions controlling sympathetic output in Lewy body disease.
    Benarroch EE; Schmeichel AM; Low PA; Boeve BF; Sandroni P; Parisi JE
    Brain; 2005 Feb; 128(Pt 2):338-44. PubMed ID: 15634729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
    Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
    Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG
    Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy.
    Komori T; Ishizawa K; Arai N; Hirose T; Mizutani T; Oda M
    Acta Neuropathol; 2003 Jul; 106(1):66-70. PubMed ID: 12669242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lewy bodies, a misleading marker for Parkinson's disease?].
    Duyckaerts C; Hauw JJ
    Bull Acad Natl Med; 2003; 187(2):277-92; discussion 292-3. PubMed ID: 14556441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.